2024
Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults
Sanford B, Brownstein N, Baker N, Palmer A, Smith T, Rojewski A, Toll B. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Internal Medicine 2024, 184: 106-108. PMID: 37955869, PMCID: PMC10644245, DOI: 10.1001/jamainternmed.2023.5239.Peer-Reviewed Original Research
2013
Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement
Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS, Tobacco and Cancer W. Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement. Clinical Cancer Research 2013, 19: 1941-1948. PMID: 23570694, PMCID: PMC5992896, DOI: 10.1158/1078-0432.ccr-13-0666.Peer-Reviewed Original ResearchConceptsTobacco useTobacco cessationCessation interventionsEvidence-based cessation interventionsTreatment-related toxicitySecond primary tumorsTobacco cessation interventionsQuality cancer careQuality of lifeAmerican AssociationCessation assistancePoor outcomeCancer careCancer patientsPrimary tumorOncology settingCancer recurrencePatientsTreatment efficacyTreatment settingsEvidence-based proceduresCancer leadCancerCancer progressionClinical infrastructure
2010
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial
Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O’Malley S. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial. Drug And Alcohol Dependence 2010, 111: 200-206. PMID: 20542391, PMCID: PMC3771701, DOI: 10.1016/j.drugalcdep.2010.04.015.Peer-Reviewed Original ResearchConceptsWeight gainSmoking cessationPoint prevalence smoking abstinence ratePre-specified primary outcomesLow-dose naltrexoneOpen-label therapySmoking abstinence ratesPoint prevalence abstinenceReduced weight gainNaltrexone augmentationPlacebo groupNicotine replacementPrimary outcomeQuit dateAbstinence ratesLabel therapyNicotine patchBehavioral counselingNaltrexoneAbstinent participantsSmokersWeight concernsWeeksCessationLower ratesRandomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation
Toll BA, Martino S, Latimer A, Salovey P, O'Malley S, Carlin-Menter S, Hopkins J, Wu R, Celestino P, Cummings KM. Randomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation. Journal Of The National Cancer Institute 2010, 102: 96-106. PMID: 20056957, PMCID: PMC2808347, DOI: 10.1093/jnci/djp468.Peer-Reviewed Original ResearchConceptsNew York State Smokers' QuitlineState Smokers' QuitlineSmoking cessationGain-framed messagesNicotine replacement therapySmoking cessation effortsCancer-related mortalitySmoking accountsCessation effortsReplacement therapyEligible callersQuitlineTreatment fidelityCessationCounselingSmokersHigh rateSpecialist trainingLarge proportionSpecialistsTherapyFollowMortalityAbstinenceEarly success